Brian Abrahams
Stock Analyst at RBC Capital
(4.57)
# 963
Out of 5,082 analysts
1837
Total ratings
49.7%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Reiterated: Hold | $114 | $116.60 | -2.23% | 142 | Oct 27, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | $6 → $2.5 | $1.30 | +92.31% | 12 | Oct 23, 2026 | |
| GILD Gilead Sciences | Reiterated: Hold | $126 | $159.08 | -20.79% | 216 | Oct 21, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $66 | $37.08 | +77.99% | 24 | Oct 19, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Hold | $17 | $11.93 | +42.50% | 12 | Oct 16, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $187 | $146.00 | +28.08% | 98 | Oct 13, 2026 | |
| NRIX Nurix Therapeutics | Rated: Buy | $36 → $35 | $26.70 | +31.09% | 12 | Oct 12, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $19 → $17 | $18.89 | -10.01% | 137 | Oct 9, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $37 → $36 | $20.17 | +78.48% | 17 | Oct 8, 2026 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Hold | $11 | $8.10 | +35.80% | 102 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $256 | $252.73 | +1.29% | 202 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $737 → $810 | $816.10 | -0.75% | 87 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $570 → $576 | $521.03 | +10.55% | 153 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 → $75 | $62.09 | +20.79% | 103 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $36.01 | +94.39% | 36 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 → $45 | $31.82 | +41.42% | 60 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $21 | $8.99 | +133.59% | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $21 | $5.16 | +306.98% | 7 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $15.00 | +200.00% | 2 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $112 | $117.57 | -4.74% | 9 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3681 | +1,258.33% | 22 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.48 | +1,566.67% | 109 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $4.15 | +767.47% | 33 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.8571 | +133.35% | 31 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $21.96 | +82.15% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $23 → $5 | $3.87 | +29.20% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.124 | +706.45% | 7 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $42 | $20.02 | +109.79% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $8.81 | +47.56% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 | $85.56 | +49.60% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 | $49.79 | n/a | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $15 | $12.18 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $288 | $14.80 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.26 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $447.95 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $4.45 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $228.23 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $16.75 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $134.19 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $11.23 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $46.27 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $72.82 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $24.28 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $10.13 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $119.97 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $30.15 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $21.84 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $56.38 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $91.13 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $55.35 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $286.39 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $61.55 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.65 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,281.91 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $268.73 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.05 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $141.82 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $29.80 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $156.86 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $50.55 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.53 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.02 | n/a | 1 | Sep 2, 2009 |
Incyte
Oct 27, 2026
Reiterated: Hold
Price Target: $114
Current: $116.60
Upside: -2.23%
Aardvark Therapeutics
Oct 23, 2026
Reiterated: Hold
Price Target: $6 → $2.5
Current: $1.30
Upside: +92.31%
Gilead Sciences
Oct 21, 2026
Reiterated: Hold
Price Target: $126
Current: $159.08
Upside: -20.79%
Definium Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $66
Current: $37.08
Upside: +77.99%
MoonLake Immunotherapeutics
Oct 16, 2026
Reiterated: Hold
Price Target: $17
Current: $11.93
Upside: +42.50%
Neurocrine Biosciences
Oct 13, 2026
Reiterated: Buy
Price Target: $187
Current: $146.00
Upside: +28.08%
Nurix Therapeutics
Oct 12, 2026
Rated: Buy
Price Target: $36 → $35
Current: $26.70
Upside: +31.09%
Sarepta Therapeutics
Oct 9, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $18.89
Upside: -10.01%
Acadia Pharmaceuticals
Oct 8, 2026
Reiterated: Buy
Price Target: $37 → $36
Current: $20.17
Upside: +78.48%
BioCryst Pharmaceuticals
Oct 8, 2026
Reiterated: Hold
Price Target: $11
Current: $8.10
Upside: +35.80%
Oct 8, 2026
Reiterated: Buy
Price Target: $260 → $256
Current: $252.73
Upside: +1.29%
Oct 8, 2026
Reiterated: Hold
Price Target: $737 → $810
Current: $816.10
Upside: -0.75%
Oct 8, 2026
Reiterated: Buy
Price Target: $570 → $576
Current: $521.03
Upside: +10.55%
Oct 7, 2026
Reiterated: Hold
Price Target: $85 → $75
Current: $62.09
Upside: +20.79%
Oct 1, 2026
Reiterated: Buy
Price Target: $70
Current: $36.01
Upside: +94.39%
Sep 23, 2026
Upgraded: Buy
Price Target: $26 → $45
Current: $31.82
Upside: +41.42%
Sep 21, 2026
Reiterated: Buy
Price Target: $23 → $21
Current: $8.99
Upside: +133.59%
Sep 8, 2026
Reiterated: Buy
Price Target: $29 → $21
Current: $5.16
Upside: +306.98%
Sep 2, 2026
Reiterated: Buy
Price Target: $45
Current: $15.00
Upside: +200.00%
Sep 2, 2026
Reiterated: Hold
Price Target: $112
Current: $117.57
Upside: -4.74%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.3681
Upside: +1,258.33%
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $0.48
Upside: +1,566.67%
Aug 12, 2026
Reiterated: Buy
Price Target: $36
Current: $4.15
Upside: +767.47%
Aug 11, 2026
Reiterated: Hold
Price Target: $2
Current: $0.8571
Upside: +133.35%
Aug 10, 2026
Reiterated: Buy
Price Target: $40
Current: $21.96
Upside: +82.15%
Aug 10, 2026
Upgraded: Hold
Price Target: $23 → $5
Current: $3.87
Upside: +29.20%
Aug 9, 2026
Reiterated: Hold
Price Target: $1
Current: $0.124
Upside: +706.45%
Aug 6, 2026
Reiterated: Buy
Price Target: $40 → $42
Current: $20.02
Upside: +109.79%
Aug 6, 2026
Reiterated: Hold
Price Target: $13
Current: $8.81
Upside: +47.56%
Apr 7, 2026
Reiterated: Buy
Price Target: $128
Current: $85.56
Upside: +49.60%
Oct 26, 2025
Reiterated: Buy
Price Target: $39.00
Current: $49.79
Upside: n/a
Oct 2, 2023
Reiterated: Hold
Price Target: $25 → $15
Current: $12.18
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: $288
Current: $14.80
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: $4
Current: $2.26
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $447.95
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $4.45
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $228.23
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $16.75
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $134.19
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $11.23
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $46.27
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $72.82
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $24.28
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $10.13
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $119.97
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $30.15
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $21.84
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $56.38
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $91.13
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $55.35
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $286.39
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $61.55
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $6.65
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,281.91
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $268.73
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $1.05
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $141.82
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $29.80
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $156.86
Upside: n/a
Feb 23, 2015
Reiterated: Hold
Price Target: n/a
Current: $50.55
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.53
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $10.02
Upside: n/a